Arcturus Therapeutics Holdings Inc. (ARCT)
NASDAQ: ARCT · Real-Time Price · USD
8.31
-0.05 (-0.60%)
Nov 16, 2026, 4:00 PM EST - Market closed

ARCT Financials Overview

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
30.5182.03152.31166.820612.36
Revenue Growth
-68.74%-46.14%-8.69%-19.03%1566.79%29.56%
Gross Profit
-50-30.18-42.85-25.3358.25-161.4
Operating Income
-94.97-76.26-95.67-78.2112.18-202.85
Net Income
-87.24-65.78-80.94-29.739.35-203.67
Earnings Per Share
-3.08-2.40-3.00-1.120.35-7.74
EPS Growth
------

Cash & Debt

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
184.82230.91237.03292.01391.88370.49
Total Debt
21.872528.5530.2294.7669.15
Net Cash (Debt)
162.95205.91208.48261.79297.13301.35
Net Cash Growth
5.56%-1.23%-20.36%-11.89%-1.40%-31.85%
Net Cash Per Share
5.757.527.729.8310.9711.45

Cash Flow & CapEx

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
-62.48-74.27-59.75-18.131.99-135.04
Capital Expenditures
0.04-0.23-0.65-2.9-7.73-3.41
Free Cash Flow
-62.45-74.5-60.4-2124.27-138.45
Free Cash Flow Growth
------

Margins

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
-163.87%-36.79%-28.13%-15.19%28.28%-
Operating Margin
-311.24%-92.97%-62.81%-46.89%5.91%-1641.33%
Pretax Margin
-285.93%-80.19%-53.14%-16.72%5.17%-1647.98%
Profit Margin
-285.92%-80.19%-53.14%-17.82%4.54%-1647.98%
FCF Margin
-204.66%-90.82%-39.65%-12.59%11.78%-1120.23%

Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingNov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PE Ratio
----48.17-
Forward PE
-118.08118.08118.08118.084.34
P/FCF Ratio
----18.56-
PS Ratio
7.852.123.025.052.1978.94